Dec 23 (Reuters) - The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from Eli Lilly (LLY.N), opens new tab ...

Since the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and tirzepatide ... and Baker’s lab continues to create start-ups that aim to turn de novo designed proteins into medicines.